Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Kidney transplant at least 1 year prior~* Subjects with a functioning renal allograft with calculated glomerular filtration rate (GFR) ≥40mL/min (Nankivell method) and proteinuria ≤500mg/day.~* Stable on cyclosporine or tacrolimus-based multi-drug immunosuppressive regimen~* History of NMSC within last 3 years~Exclusion Criteria:~* History of other cancer within last 3 years~* NMSC with metastatic disease or more than 20 NMSC lesions in last 12 months~* Multiple organ transplant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Conversion to a sirolimus-based regimen
- 2 (Type: ACTIVE_COMPARATOR): Continuation of a CNI-based regimen

Based on this trial design, predict the completion outcome and termination type (if applicable).